Moderna (MRNA) Current Taxes (2021 - 2024)
Moderna (MRNA) posted quarterly Current Taxes of $4.0 million for Q3 2024, down 92.86% year-over-year from $56.0 million in Q4 2023, and down 42.86% on a QoQ basis from $7.0 million in Q2 2024.
Moderna (MRNA) Current Taxes (2021 - 2024) Analysis & Trends
Moderna has reported Current Taxes for 4 years, with the latest figure at $4.0 million in Q3 2024.
- Current Taxes for Q3 2024 came in at $4.0 million, down 92.86% year-over-year; the trailing twelve-month figure through Sep 2024 was $4.0 million (down 92.86% YoY), and the FY2023 annual result was $63.0 million, up 31.25% from the prior year.
- Current Taxes declined to $4.0 million in Q3 2024, from $7.0 million in the prior quarter.
- Over five years, Current Taxes peaked at $1.6 billion in Q1 2022 and troughed at $4.0 million in Q3 2024.
- A 4-year average of $291.6 million and a median of $63.0 million in 2023 frame the typical range for Current Taxes.
- The largest YoY upside for Current Taxes was 31.25% in 2023 against a maximum downside of 95.85% in 2023.
- A 4-year view of Current Taxes shows it stood at $876.0 million in 2021, then plunged by 94.52% to $48.0 million in 2022, then jumped by 31.25% to $63.0 million in 2023, then plunged by 93.65% to $4.0 million in 2024.
- Per Business Quant data, the three most recent Current Taxes figures were $4.0 million in Q3 2024, $7.0 million in Q2 2024, and $52.0 million in Q1 2024.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Current Taxes (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | - |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | 49.00 Mn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | - |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 76.32 Mn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | 59,089.99 |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | - |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | - |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | - |
| 10 | Moderna | 25.26 Bn | 20.13 Bn | 52.00 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2024 | 4.00 Mn |
| Jun 30, 2024 | 7.00 Mn |
| Mar 31, 2024 | 52.00 Mn |
| Dec 31, 2023 | 63.00 Mn |
| Sep 30, 2023 | 56.00 Mn |
| Jun 30, 2023 | 47.00 Mn |
| Mar 31, 2023 | 66.00 Mn |
| Dec 31, 2022 | 48.00 Mn |
| Sep 30, 2022 | 66.00 Mn |
| Jun 30, 2022 | 349.00 Mn |
| Mar 31, 2022 | 1.59 Bn |
| Dec 31, 2021 | 876.00 Mn |
| Sep 30, 2021 | 565.00 Mn |